So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance
Research-grade quality assurance requires using product within the stated shelf life
Currently, patient leaflets list pancreatitis as an uncommon side effect, but regulators are seeking more data to clarify risk
You will learn what helps your hunger feel quieter, what keeps your energy steady, and how sleep, stress, and movement work together with hormones and metabolism
Extra tests are only needed if signs are unusual or suggest another eye problem